Literature DB >> 15221938

Gastrokine 1 is abundantly and specifically expressed in superficial gastric epithelium, down-regulated in gastric carcinoma, and shows high evolutionary conservation.

Karin A Oien1, Fiona McGregor, Sharlene Butler, Rod K Ferrier, Ian Downie, Steven Bryce, Sharon Burns, W Nicol Keith.   

Abstract

Through previous large-scale gene expression profiling we identified a transcript that was abundant in normal stomach and down-regulated in gastric cancer. Genes expressed at similar levels included gastrin, MUC5 and pS2, which are important in gastric function. We aimed to characterise this candidate, gastrokine 1 (GKN1), at mRNA, DNA, protein and tissue levels. The gene was studied in human, mouse, rat and cow, and was highly conserved across these species. The mRNA transcripts averaged 750 bp in length. The human, mouse and rat genes all contained six exons spanning 6 kb, and were located on chromosomes 2, 6 and 4 respectively. The full-length translation products were 183-185 amino acids long, reducing to the mature protein of 18 kDa following signal peptide cleavage; these predictions were confirmed by Western blotting. Tagged gastrokine 1 yielded granular cytoplasmic staining with perinuclear accentuation, representing the Golgi apparatus, in keeping with secretion or expression on the extracellular surface. Gene expression in tissues was profiled extensively by Northern blotting, in situ hybridisation and immunohistochemistry. Gastrokine 1 was highly expressed in normal stomach, where it was located in the superficial/foveolar gastric epithelium, but was absent from gastric carcinomas. Outwith the stomach, gastrokine 1 was found only in epithelia showing gastric metaplasia eg Barrett's oesophagus, the ulcer-associated cell lineage and ovarian mucinous neoplasms. In conclusion, we have characterised gastrokine 1, previously known as CA11, AMP-18 or foveolin. Its abundance in, and specificity for, native or metaplastic gastric epithelium, down-regulation in gastric carcinoma and evolutionary conservation suggest that this gene is physiologically important in the stomach. The function of gastrokine 1 is unknown but a role in mucosal protection is postulated. Copyright 2004 Pathological Society of Great Britain and Ireland.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15221938     DOI: 10.1002/path.1583

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  45 in total

1.  Selective gene expression by rat gastric corpus epithelium.

Authors:  M Goebel; A Stengel; N W G Lambrecht; G Sachs
Journal:  Physiol Genomics       Date:  2010-12-21       Impact factor: 3.107

2.  Gastrokine 1 protein is a potential theragnostic target for gastric cancer.

Authors:  Jung Hwan Yoon; In-Hye Ham; Olga Kim; Hassan Ashktorab; Duane T Smoot; Suk Woo Nam; Jung Young Lee; Hoon Hur; Won Sang Park
Journal:  Gastric Cancer       Date:  2018-04-27       Impact factor: 7.370

3.  Gastrokine-2 is downregulated in gastric cancer and its restoration suppresses gastric tumorigenesis and cancer metastasis.

Authors:  Jin Dai; Ning Zhang; Jinhui Wang; Minhu Chen; Jie Chen
Journal:  Tumour Biol       Date:  2014-01-10

4.  Database of mRNA gene expression profiles of multiple human organs.

Authors:  Chang Gue Son; Sven Bilke; Sean Davis; Braden T Greer; Jun S Wei; Craig C Whiteford; Qing-Rong Chen; Nicola Cenacchi; Javed Khan
Journal:  Genome Res       Date:  2005-03       Impact factor: 9.043

5.  Control of cognition and adaptive behavior by the GLP/G9a epigenetic suppressor complex.

Authors:  Anne Schaefer; Srihari C Sampath; Adam Intrator; Alice Min; Tracy S Gertler; D James Surmeier; Alexander Tarakhovsky; Paul Greengard
Journal:  Neuron       Date:  2009-12-10       Impact factor: 17.173

6.  Nkx2-1 represses a latent gastric differentiation program in lung adenocarcinoma.

Authors:  Eric L Snyder; Hideo Watanabe; Margaret Magendantz; Sebastian Hoersch; Tiffany A Chen; Diana G Wang; Denise Crowley; Charles A Whittaker; Matthew Meyerson; Shioko Kimura; Tyler Jacks
Journal:  Mol Cell       Date:  2013-03-21       Impact factor: 17.970

7.  Evolution of the human gastrokine locus and confounding factors regarding the pseudogenicity of GKN3.

Authors:  Jessica H Geahlen; Carlo Lapid; Kaisa Thorell; Igor Nikolskiy; Won Jae Huh; Edward L Oates; Jochen K M Lennerz; Xiaolin Tian; Victoria G Weis; Shradha S Khurana; Samuel B Lundin; Alan R Templeton; Jason C Mills
Journal:  Physiol Genomics       Date:  2013-05-28       Impact factor: 3.107

8.  Gastrokine 1 regulates NF-κB signaling pathway and cytokine expression in gastric cancers.

Authors:  Jung Hwan Yoon; Mi La Cho; Yoo Jin Choi; Ji Yeon Back; Mi Kyung Park; Suk Woo Lee; Byung Joon Choi; Hassan Ashktorab; Duane T Smoot; Suk Woo Nam; Jung Young Lee; Won Sang Park
Journal:  J Cell Biochem       Date:  2013-08       Impact factor: 4.429

Review 9.  Exploring the role of molecular biomarkers as a potential weapon against gastric cancer: A review of the literature.

Authors:  Marwa Matboli; Sarah El-Nakeep; Nourhan Hossam; Alaa Habieb; Ahmed E M Azazy; Ali E Ebrahim; Ziad Nagy; Omar Abdel-Rahman
Journal:  World J Gastroenterol       Date:  2016-07-14       Impact factor: 5.742

10.  Loss of gastrokine-2 drives premalignant gastric inflammation and tumor progression.

Authors:  Trevelyan R Menheniott; Louise O'Connor; Yok Teng Chionh; Jan Däbritz; Michelle Scurr; Benjamin N Rollo; Garrett Z Ng; Shelley Jacobs; Angelique Catubig; Bayzar Kurklu; Stephen Mercer; Toshinari Minamoto; David E Ong; Richard L Ferrero; James G Fox; Timothy C Wang; Philip Sutton; Louise M Judd; Andrew S Giraud
Journal:  J Clin Invest       Date:  2016-03-14       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.